Publication

Byline

'Borders are dangerous': Awarapan fame Pakistani singer Mustapha Zahid reacts to Amaal Mallik recreating songs in sequel

India, July 1 -- When Awarapan was released in 2007, it quickly became a cult success. Part of the film's appeal was its music, particularly To Phir Aao and Tera Mera Rishta, which became synonymous w... और पढ़ें


LG reviews arrangements for pilgrims at Bhagwati Nagar Yatri Niwas

JAMMU, July 1 -- Lieutenant Governor Shri Manoj Sinha on Wednesday visited the Yatri Niwas at Bhagwati Nagar in Jammu and reviewed arrangements in place for the pilgrims ahead of Shri Amarnath Ji Yatr... और पढ़ें


Vitamin Deficiency Signs You Shouldn't Ignore

Srinagar, July 1 -- You brush off tiredness, blame stress for low energy and call it just a phase, but what if your body is actually low on essential nutrients? Vitamin deficiency does not crash your ... और पढ़ें


Vijaya Mehta's pioneering contribution to Marathi theatre & Indian cinema inspired generations of artists: Rahul Gandhi

New Delhi, July 1 -- Leader of Opposition in the Lok Sabha and Congress MP, Rahul Gandhi, on Wednesday expressed his condolences over the passing of renowned theatre director, actor, and filmmaker Vij... और पढ़ें


Singapore Clinical Trial: A Phase 1, Investigator- and Participant-Blinded, Placebo-Controlled, Randomized, Multiple-Dose Study to Evaluate the Gastric Emptying Delay, Pharmacokinetics, Safety, and Tolerability of Eloralintide in Participants with Obesity or Overweight

Singapore, July 1 -- The Health Sciences Authority received information related to the study titled 'A Phase 1, Investigator- and Participant-Blinded, Placebo-Controlled, Randomized, Multiple-Dose Stu... और पढ़ें


Singapore Clinical Trial: A Phase 1 randomized, double-blind, placebo-controlled, single-ascending-dose study investigating the safety and tolerability of ARD001 in healthy adult subjects and a Phase 2 open-label, multiple-dose study in adult subjects with hemophilia A

Singapore, July 1 -- The Health Sciences Authority received information related to the study titled 'A Phase 1 randomized, double-blind, placebo-controlled, single-ascending-dose study investigating t... और पढ़ें


Singapore Clinical Trial: A Multinational, Multicenter Study With an Open-Label Phase 1b and a Randomized, Double-Blind, Placebo-Controlled Phase 3 Followed by an Open-Label Extension to Assess the Efficacy, Safety, Tolerability, and Pharmacokinetics of Radiprodil in Participants With GRIN-Related Neurodevelopmental Disorder

Singapore, July 1 -- The Health Sciences Authority received information related to the study titled 'A Multinational, Multicenter Study With an Open-Label Phase 1b and a Randomized, Double-Blind, Plac... और पढ़ें


Singapore Clinical Trial: A Global, Multicenter, Prospective, Controlled, Open-Label Pivotal Study of Iodofalan (131I) Solution for Injection (TLX101-Tx) Plus Lomustine Versus Lomustine Alone in Patients with Radiographically Confirmed Recurrent Glioblastoma at First Recurrence (IPAX-3)

Singapore, July 1 -- The Health Sciences Authority received information related to the study titled 'A Global, Multicenter, Prospective, Controlled, Open-Label Pivotal Study of Iodofalan (131I) Soluti... और पढ़ें


Singapore Clinical Trial: RASolute 303: A Phase 3 Global, Multicenter, Open-label, Randomized, 3-Arm Study of Daraxonrasib Monotherapy or Daraxonrasib Plus Gemcitabine and Nab-paclitaxel versus Gemcitabine and Nab-paclitaxel as a First-Line Treatment for Patients with Metastatic Pancreatic Adenocarcinoma

Singapore, July 1 -- The Health Sciences Authority received information related to the study titled 'RASolute 303: A Phase 3 Global, Multicenter, Open-label, Randomized, 3-Arm Study of Daraxonrasib Mo... और पढ़ें


Singapore Clinical Trial: A Multicenter, Multi-Part, Phase 1/2 Study of EIK1005 as Monotherapy and in Combination with Pembrolizumab in Participants with Advanced Solid Tumors, including Participants with Microsatellite Instability High (MSI-H) or Mismatch Repair Deficient (dMMR) Tumors

Singapore, July 1 -- The Health Sciences Authority received information related to the study titled 'A Multicenter, Multi-Part, Phase 1/2 Study of EIK1005 as Monotherapy and in Combination with Pembro... और पढ़ें